The World Health Organization (WHO) has reported a landmark achievement in global eye health: the number of people requiring interventions against trachoma, the world’s leading infectious cause of blindness, has fallen below 100 million for the first time in history. In 2002, 1.5 billion people were at risk, and as recently as 2011, 314 million people required interventions. The decline to 97.1 million by November 2025 represents a 94% reduction, reflecting decades of coordinated global efforts.
This success is largely credited to the SAFE strategy endorsed by WHO, which combines Surgery for trachomatous trichiasis, Antibiotics to clear infections, Facial cleanliness, and Environmental improvement. Countries across Africa, Asia, and the Middle East have implemented these interventions at scale, with national health ministries partnering with local communities and international organisations to ensure widespread reach and sustainability.
The global reduction in trachoma cases demonstrates both preventive and curative approaches. Large-scale antibiotic distribution campaigns and targeted surgical interventions have been complemented by educational programmes promoting facial hygiene and improved sanitation. Innovative data collection tools, including Tropical Data systems, have helped track progress and allocate resources effectively, ensuring interventions reach the most vulnerable populations.
WHO highlights that this milestone represents not only a reduction in disease prevalence but also a major public health achievement for global development and social equity. The progress shows how structured, evidence-based interventions can achieve tangible impact, prevent avoidable blindness, and strengthen health systems in endemic regions.
Strategic significance lies in demonstrating the effectiveness of sustained, multi-level public health interventions. The WHO achievement provides a model for other infectious disease elimination campaigns, reinforcing compliance with global health standards and ESG principles in the health sector. For donors, governments, and private partners, this milestone underlines the value of long-term investments in preventive healthcare and data-driven implementation to deliver measurable social and economic returns.
